Amicus therapeutics Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Amicus therapeutics Contact Number

Amicus Therapeutics How to Contact Us

5 hours ago Amicusrx.com Show details

Category: Contact SupportShow more

Amicus Therapeutics, Inc. Company Profile Philadelphia

7 hours ago Dnb.com Show details

(215) 921-7600

3675 Market St Ste 1400. Philadelphia , PA , 19104-5696. United States. See other locations. Phone. (215) 921-7600. Company Description. Amicus Therapeutics develops drugs that treat rare genetic diseases known as lysosomal storage disorders. Unlike other treatments which replace defective enzymes, Amicus' lead drug, Galafold, is an oral small

Employees: 325
Cash and Cash Equivalents: $163.24
Accounts Receivable: $46.92
Location: 3675 Market St Ste 1400, Philadelphia, 19104-5696, PA

Category: Contact NumberShow more

Amicus Therapeutics Advancing Therapies to Treat Rare

5 hours ago Amicusrx.com Show details

Amicus Therapeutics) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering high-quality medicines for people living …

Category: Contact NumberShow more

Amicus Therapeutics Crunchbase Company Profile & Funding

9 hours ago Crunchbase.com Show details

Contact Email [email protected] Phone Number (609)662-200. Amicus Therapeutics (Nasdaq:FOLD) is a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases. The Company has a robust pipeline of novel, first-in-class, small molecules called pharmacological chaperones for the treatment of lysosomal storage

Founder: John Crowley
Location: Cranbury, New Jersey
Founded: Jul 01, 2007

Category: Contact NumberShow more

AMICUS THERAPEUTICS SAS Company Profile PUTEAUX, ILEDE

7 hours ago Dnb.com Show details

AMICUS THERAPEUTICS SAS has 6 employees at this location and generates $8.06 million in sales (USD). D&B Hoovers provides sales leads and sales intelligence data on over 120 million companies like AMICUS THERAPEUTICS SAS around the world, including contacts, financials, and …

Employees: 6
Phone: 72757254
Location: IMMEUBLE MAISON DE LA DEFENSE12 PLACE DE LA DEFENSE, PUTEAUX, 92800

Category: Contact NumberShow more

Contact Us Amicus Attorney

9 hours ago Amicusattorney.com Show details

800 726-3339

For assistance or to contact the Amicus and AbacusLaw teams at AbacusNext, call 800 726-3339, or fill out the form: Country * Questions/Comments ? AbacusNext is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us.

Category: Contact SupportShow more

Careers Opportunities Amicus Therapeutics

2 hours ago Amicusrx.com Show details

Category: Contact NumberShow more

AMICUS THERAPEUTICS UK LIMITED Company Profile MARLOW

4 hours ago Dnb.com Show details

Find company research, competitor information, contact details & financial data for AMICUS THERAPEUTICS UK LIMITED of MARLOW. Get the latest business insights from Dun & Bradstreet.

Category: Contact NumberShow more

Amicus Therapeutics Development Pipeline

2 hours ago Amicusrx.com Show details

Development Pipeline. At Amicus we are business led and science driven to deliver meaningful benefits to patients. We believe that our advanced product pipeline and platform technologies uniquely position us at the forefront of developing therapies to potentially address significant unmet needs for …

Category: Contact NumberShow more

Amicus Therapeutics Inc Company Profile and News

9 hours ago Bloomberg.com Show details

Company profile page for Amicus Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information

Category: Contact NumberShow more

Amicus Therapeutics Email Format amicustherapeutics.com

2 hours ago Rocketreach.co Show details

Amicus Therapeutics Email Format. Amicus Therapeutics uses 1 email formats, with first_initial last (ex. [email protected]) being used 100.0% of the time. Get Verified Emails for Amicus Therapeutics Employees. Amicus Therapeutics's Email Format. Percentage.

Category: Contact NumberShow more

Amicus Trust

8 hours ago Amicustrust.org Show details

Amicus Trust provides support and accommodation for homeless individuals in Bedfordshire, Northamptonshire, Buckinghamshire, Cambridgeshire and Leicester. Published: 3 rd …

Category: Contact NumberShow more

GALAFOLD® (migalastat) contact us for HCPS Amicus

2 hours ago Galafold.co.uk Show details

Amicus will process, both electronically and manually, your personal information and contact details, including(e.g. your name, title, postal and email address and phone number) as well as professional information about you including your employer, field of expertise and specialisation, your publications, your interest in Amicus products and

Category: Contact SupportShow more

Amicus Therapeutics Number of Employees 20072021 FOLD

6 hours ago Macrotrends.net Show details

Number of Employees. Amicus Therapeutics number of employees from 2007 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Compare FOLD With Other Stocks. Select a timeframe to show chart data.

Category: Contact NumberShow more

Amicus Therapeutics and ARYA Sciences Acquisition Corp IV

6 hours ago Ir.amicusrx.com Show details

Business Combination of Amicus Gene Therapy Business with ARYA IV to Result in the Launch of Caritas Therapeutics, a New Independent, Publicly Traded Company with Expected ~$400M in Initial Funding Will Transform Amicus into a Premier Global Commercialization and Late Stage Product Development Biotechnology Company in Rare Diseases. Transaction Advances Amicus

Category: Contact NumberShow more

Amicus Therapeutics Announces First Quarter 2021 Financial

7 hours ago Ir.amicusrx.com Show details

To report Suspected Adverse Reactions, contact Amicus Therapeutics at 1-877-4AMICUS or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. For additional information about Galafold, including the full U.S. Prescribing Information, please visit https://www.amicusrx.com/pi/Galafold.pdf. EU Important Safety Information

Category: Contact NumberShow more

Amicus Therapeutics Information Amicus Therapeutics Profile

7 hours ago Rocketreach.co Show details

Amicus Therapeutics is a global biotechnology company at the forefront of therapies for rare and orphan diseases. We have a unique set of platform technologies and medicines in development for people living with rare and devastating diseases, including the Lysosomal Storage Disorders Fabry disease and Pompe disease, as well as the genetic connective skin disorder Epidermolysis Bullosa (EB).

Category: Contact NumberShow more

PharmaBoardroom Mattias Bankel General Manager, Head

4 hours ago Pharmaboardroom.com Show details

Sweden Rare Diseases Amicus Fabry Disease Reimbursement Strategy. Amicus Therapeutics is a biotechnology company at the forefront of advanced therapies to treat a range of devastating rare and orphan diseases. Mattias Bankel, Head of Nordics and Baltics, shares his journey of establishing and developing Amicus’s presence in Sweden and other

Category: Contact NumberShow more

Events & Presentations Amicus Therapeutics

8 hours ago Ir.amicusrx.com Show details

BTIG Virtual Biotechnology Conference 2021. Aug 9, 2021 at 9:00 AM EDT. BTIG hosted events are intended for prospective and existing BTIG clients only. To listen to the live event, please contact your BTIG representative with interest. Amicus Second Quarter 2021 Results Conference Call and Webcast. Aug 5, 2021 at 8:30 AM EDT.

Category: Contact NumberShow more

Farah Mondelus Email, Phone Clinical Trial Manager

3 hours ago Adapt.io Show details

Find Farah Mondelus's accurate email address and contact/phone number in Adapt.io. Currently working as Clinical Trial Manager at Amicus Therapeutics in New jersey, United States.

Category: Phone NumberShow more

U.S. FDA Accepts Filings for Amicus’ ATGAA for the

6 hours ago Ir.amicusrx.com Show details

PHILADELPHIA, Sept. 29, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for cipaglucosidase alfa and the New Drug Application (NDA) for miglustat for AT-GAA, the Company’s investigational two-component

Category: Contact NumberShow more

Amicus Therapeutics Announces Upcoming Presentations at

2 hours ago Ir.amicusrx.com Show details

With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company’s website at www.amicusrx.com, and follow us on Twitter and LinkedIn. CONTACT: Investors: Andrew Faughnan

Category: Contact NumberShow more

Galafold.com The first and only oral therapy for Fabry

5 hours ago Galafold.com Show details

Galafold is a prescription medicine used to treat adults with Fabry disease who have a certain genetic change (variant) in the galactosidase alpha gene ( GLA) that is responsive (amenable) to Galafold. It is not known if Galafold is safe and effective in children. You …

Category: Contact NumberShow more

U.S. FDA Accepts Filings for Amicus’ ATGAA for the

4 hours ago Finance.yahoo.com Show details

PHILADELPHIA, Sept. 29, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License

Category: Contact NumberShow more

Amicus Therapeutics and ARYA Sciences Acquisition Corp IV

1 hours ago Finance.yahoo.com Show details

Business Combination of Amicus Gene Therapy Business with ARYA IV to Result in the Launch of Caritas Therapeutics, a New Independent, Publicly Traded Company with …

Category: Contact NumberShow more

Amicus Therapeutics to split into two businesses through

7 hours ago Bizjournals.com Show details

Amicus Therapeutics Inc., a life sciences company which at the start of this year moved it headquarters from New Jersey to Philadelphia, unveiled …

Category: Contact NumberShow more

Amicus deal puts it on path to profitability, infuses its

4 hours ago Medcitynews.com Show details

Pharma, BioPharma. Amicus deal puts it on path to profitability, infuses its gene therapies with $400M Amicus Therapeutics is spinning its …

1. Author: Frank Vinluan

Category: Contact NumberShow more

U.S. FDA Accepts Filings for Amicus’ ATGAA for the

2 hours ago Globenewswire.com Show details

Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel …

Category: Contact NumberShow more

Amicus Therapeutics' new global research and gene therapy

8 hours ago Pharmaceutical-technology.com Show details

Category: Contact NumberShow more

John F. Crowley Net Worth, Biography & Insider Trading History

5 hours ago Insidertrades.com Show details

(215) 921-7600

The corporate mailing address for Mr. Crowley and other Amicus Therapeutics executives is 1 Cedar Brook Drive, Cranbury NJ, 08512. Amicus Therapeutics can also be reached via phone at (215) 921-7600 and via email at [email protected]

Category: Contact NumberShow more

Amicus Therapeutics Company Profile Office Locations

6 hours ago Craft.co Show details

Amicus Therapeutics has 584 employees across 11 locations and $260.89 M in annual revenue in FY 2020. See insights on Amicus Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Category: Contact NumberShow more

Analysts Estimate Amicus Therapeutics (FOLD) to Report a

8 hours ago Finance.yahoo.com Show details

For the last reported quarter, it was expected that Amicus Therapeutics would post a loss of $0.23 per share when it actually produced a loss of $0.25, delivering a surprise of -8.70%.

Category: Contact NumberShow more

Amicus Therapeutics : U.S. FDA Accepts Filings for Amicus

7 hours ago Marketscreener.com Show details

FDA Sets PDUFA Target Action Date of May 29, 2022 for the New Drug Application and July 29, 2022 for the Biologics License Application. On Track for MAA Submission in the Fourth Quarter of this Year. PHILADELPHIA, Sept. 29, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review …

Category: Contact NumberShow more

Amicus Therapeutics Announces First Quarter 2021 Financial

9 hours ago Finance.yahoo.com Show details

Amicus Therapeutics will host a conference call and audio webcast today, May 10, 2021 at 8:30 a.m. ET to discuss the first quarter 2021 financial results and corporate updates.

Category: Contact NumberShow more

What Do Analysts Say About Amicus Therapeutics Inc. (FOLD

4 hours ago Baxterreport.com Show details

FOLD – Amicus Therapeutics Inc. Stock Earnings Estimates. Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 266.40 million.

Category: Contact NumberShow more

Amicus Therapeutics : Arya Sciences Acquisition Corp to

9 hours ago Marketscreener.com Show details

September 29, 2021. 09:30a: AMICUS THERAPEUTICS, INC.: Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)

Category: Contact NumberShow more

U.S. FDA Accepts Filings for Amicus’ ATGAA for the

6 hours ago Checkorphan.org Show details

With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company’s website at www.amicusrx.com, and follow us on Twitter and LinkedIn. Contact: Investors: Andrew Faughnan

Category: Contact NumberShow more

Sustainable Amicus Therapeutics's ESG performance data

7 hours ago Sustainable.com Show details

Biotechnology Amicus Therapeutics. Amicus Therapeutics Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of next-generation medicines.

Category: Contact NumberShow more

$FOLD AMICUS THERAPEUTICS, INC. Insider Trading

1 hours ago Insidermole.com Show details

619-537-9849

CIK Number: 0001178879 IRS Number: 200422823 Industry: PHARMACEUTICAL PREPARATIONS [2834] Trading Symbol: FOLD Company Address: 3675 MARKET STREET PHILADELPHIA 19104 Phone number: 619-537-9849 Former name: AMICUS THERAPEUTICS INC, date of change: 2002-07-29. Amicus Therapeutics, Inc. operates as a biotechnology company.

Category: Contact NumberShow more

Is Amicus Stock a good investment? FOLD Macroaxis

6 hours ago Macroaxis.com Show details

Amicus Therapeutics is trading at 9.66 as of the 29th of September 2021, a -5.11% down since the beginning of the trading day. The stock's lowest day price was 9.63. Get the latest Amicus Therapeutics detailed stock quotes, stock trade data, stock price info, and performance analysis, including Amicus Stock investment advice, charts, stats and more.

Category: Contact NumberShow more

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Insider Samantha

9 hours ago Marketbeat.com Show details

Amicus Therapeutics had a negative net margin of 89.53% and a negative return on equity of 91.47%. Sell-side analysts forecast that Amicus Therapeutics, Inc. will post -0.79 earnings per share for the current year. A number of large investors have recently bought and sold shares of FOLD.

Category: Contact NumberShow more

Poster: Living with lateonset Pompe disease in the UK

9 hours ago Marketscreener.com Show details

27 Total number of participants: COUNTRY Diagnosis Study [for diagnosis], by Isolation and reduced contact with family and friends has Amicus Therapeutics Inc. published this content on 16 September 2021 and is solely responsible for the information contained therein.

Category: Contact NumberShow more

A Look At Amicus Therapeutics Inc. (NASDAQ: FOLD): How

8 hours ago Marketingsentinel.com Show details

Amicus Therapeutics Inc. (NASDAQ:FOLD)’s traded shares stood at 3.54 million during the last session, with the company’s beta value hitting 1.18. At the close of trading, the stock’s price was $10.93, to imply an increase of 8.22% or $0.83 in intraday trading. The FOLD share’s 52-week high r

Category: Contact NumberShow more

John Kirk at Amicus Therapeutics AroundDeal B2B

6 hours ago Arounddeal.com Show details

Vice President, Regulatory Affairs and Quality Assurance at Amicus Therapeutics. John Kirk is the Vice President, Regulatory Affairs and Quality Assurance at …

Category: Contact NumberShow more

Is Amicus Therapeutics, Inc. (FOLD) A Good Stock To Buy

6 hours ago Insidermonkey.com Show details

Money managers were getting more optimistic. The number of long hedge fund bets rose by 4 lately. Amicus Therapeutics, Inc. (NASDAQ:FOLD) was in …

Category: Contact NumberShow more

Small Company Offering and Sale of Securities Without

6 hours ago Ih.advfn.com Show details

1 day ago · Principal Place of Business and Contact Information: Name of Issuer AMICUS THERAPEUTICS, INC. Street Address 1: Number of such non-accredited investors who already have invested in the offering : Amicus Therapeutics (NASDAQ:FOLD) Historical Stock Chart From Oct 2020 to Oct 2021

Category: Contact NumberShow more

If You Don’t Bullish On Amicus Therapeutics Inc. (NASDAQ

4 hours ago Stocksregister.com Show details

The number of analysts that have assigned FOLD a recommendation rating is 11. Out of them, 5 rate it a Hold, while 6 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Amicus Therapeutics Inc. (FOLD) as Underweight, while 0 advise Sell.

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

Why are amicus therapeutics important to the world?

At Amicus we are business led and science driven to deliver meaningful benefits to patients. We believe that our advanced product pipeline and platform technologies uniquely position us at the forefront of developing therapies to potentially address significant unmet needs for devastating rare diseases.

Do you need cookies to use amicus therapeutics?

Amicus Therapeutics informs you that our website uses its own and third party cookies to improve our services and collect statistical information about your browsing. By clicking accept, we consider that you accept its use.

What makes amicus a mission driven innovation company?

Mission-driven Innovation. We are a biotechnology company at the forefront of advanced therapies to treat a range of devastating rare diseases. At Amicus, patient-centricity is in our DNA. See how our commitment to patients goes further than just our medicines and expands out to the rare disease community at large.

Brand New Updated

Popular Brands

Amazon
Abbvie
Aia
Asml
Amgen
Att
Apple
Adobe
Aptar
Acc
Adidas
Aak
Aes